Özet:

Background and Objectives: Acute coronary syndromes (ACS) are common in Chronic Kidney Disease and are major source of short term and long term morbidity and mortality in this population. CKD represents a potent and independent risk factor for adverse outcome in ACS patients. Management of patients with CKD presenting with ACS is more complex than in thegeneral population because of the lack of well-designed Randomized trials assessing the rapeutic strategies in such patients. Among ACS patients, Chronic Kidney Disease doubles the death rates and is third only to Cardiogenic Shock and Congestive Heart Failure as apredict or of Mortality. As there is need for improved representation of patients with CKD in Randomized clinical trialsto characterise risks and benefits of medical therapies in ACS patients so as to increase Evidencebased decisions. There are limited data on the prevalence of CKD in Acute Coronary Syndromepatients in Indian population. Hence, this Study was done to determine the prevalence of CKD in ACS patients and find the Management difference in Acute Coronary Syndrome patients with CKD and without CKD and todeterminethe outcome of patientswith CKD.

Anahtar Kelimeler: